
AGM/EGM4 Sept 2026, 05:50 pm
Emmessar Biotech Announces 34th AGM on Sep 29, 2026
AI Summary
Emmessar Biotech & Nutrition Ltd. has issued a notice for its 34th Annual General Meeting (AGM) to be held on September 29, 2026, via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The meeting will commence at 10:30 a.m. Key agenda items include the adoption of Audited Financial Statements for the Financial Year ended March 31, 2026, the re-appointment of Mr. Jeyavel Balaiah Nadar as a Director, and the re-appointment of Mr. Srinivasa Raghavan Mathurakavi Ayyangar as Managing Director for a further period of 5 years. The proposed re-appointment of the Managing Director includes specific remuneration details and terms.
Key Highlights
- AGM scheduled for September 29, 2026, via VC/OAVM.
- Adoption of FY26 Audited Financial Statements is on the agenda.
- Director Jeyavel Balaiah Nadar up for re-appointment.
- MD Srinivasa Raghavan Mathurakavi Ayyangar seeks re-appointment for 5 years.
Price Impact
More from EMMESSA